Weekly Watch List

ALXN (7/24/11, +93.96%)
ALGN (9/16/12, -3.27%)
FLT (9/2/12, +3.75%)
AAPL (4/29/12, +10.63%)
TDG (9/9/12, -1.16%)
CF (9/9/12, +3.38%)
FRAN (9/23/12, +0.23%)
PNRA (9/23/12, +0.47%)
TFM (9/23/12, +1.94%)
JAH (9/9/12, +4.78%)
PII (9/23/12, -0.89%)
VAL (7/01/12, +6.88%)
TJX (3/25/12, +15.95%)
ROST (9/9/12, -3.26%)
TDC (9/30/12, +0.00%)

Additions:
TDC (9/30/12, +0.00%)

Subtractions:
None

Last week, all the major U.S. indexes moved lower. The NASDAQ dropped 2.0%, the NYSE composite slumped 1.5%, the S&P 500 lost 1.3%, and the Dow gave up 1.0%. The IBD outlook remains at “confirmed uptrend”. Chinese and European woes reared their ugly heads again and combined with poor U.S. economic data to tamp down U.S. equity enthusiasm. Institutions were selling most of the week and the resulting distribution put a good sized dent in the ongoing rally. It’s not over yet, but another week like last week will, at a minimum, put the uptrend under pressure. Have a plan ready to move over on to the defensive, just in case. This week, besides whatever news might spring forth from China or Europe or elsewhere, Friday’s September employment report looms large, not only in terms of its effect on market sentiment, but maybe even more so politically. With the elections and the “fiscal cliff” still unresolved and drawing ever closer, expect market volatility to most likely increase.

This week six of the watch list stocks are at or near proper buy points. ALXN, trading at $114.80, is still within 5% of a $110.06 buy point, off of a 4th stage flat base. ALGN, trading at $36.97, is within 5% of a $36.20 buy point, off of a 2nd stage flat base. TDG, trading at $141.87, has pulled back to within 5% of a $136.44 buy point, off of a 1st stage flat base. CF, trading at $222.24, is still in buy range up to $229.16, after finding support at its ten week line. PNRA, trading at $170.89, is still within 5% of a $164.10 buy point, off of a 1st stage cup with handle base. TDC, trading at $75.41, is still within 5% of a $73.84 buy point, off of a 2nd stage double bottom base.

/as usual, your mileage may vary, always do your own homework

Advertisements

Weekly Watch List

AAPL (4/29/12, +16.10%)
ALXN (7/24/11, +93.64%)
ALGN (9/16/12, -1.02%)
TDG (9/9/12, +0.68%)
FLT (9/2/12, +5.60%)
VAL (7/01/12, +12.06%)
FRAN (9/23/12, +0.00%)
JAH (9/9/12, +5.37%)
PII (9/23/12, +0.00%)
CF (9/9/12, +1.74%)
ROST (9/9/12, -3.26%)
TFM (9/23/12, +0.00%)
TJX (3/25/12, +15.32%)
PNRA (9/23/12, +0.00%)

Additions:
FRAN (9/23/12, +0.00%)
PII (9/23/12, +0.00%)
PNRA (9/23/12, +0.00%)
TFM (9/23/12, +0.00%)

Subtractions:
EBAY (9/16/12, -1.00%)

Last week, all the major U.S. indexes drifted lower. The Dow and the NASDAQ each faded 0.1%, the S&P 500 dipped 0.4%, and the NYSE composite slipped 1.0%. The IBD outlook remains at “confirmed uptrend”. Although the current rally is getting long in the tooth and the major indexes are already near multi-year highs, it still seems as if the markets want to move higher. Instances of distribution have been few and far between, volatility is near historic lows, and the FOMC is all in to backstop equity prices. At least for now, there’s no obvious sign that institutions are contemplating a rush for the exits anytime in the near future. The major U.S. economic data point this week will be Thursday’s final look at Q2 GDP, a significant deviation from the 1.7% consensus, in either direction, could be a market catalyst.

This week four of the watch list stocks are at or near proper buy points. ALXN, trading at $114.21, is still within 5% of a $110.06 buy point, off of a 4th stage flat base. ALGN, trading at $37.83, has pulled back to barely within 5% of a $36.20 buy point after recently breaking out of a 2nd stage flat base. CF, trading at $218.70, is still in buy range up to $229.16 after finding support at its ten week line. PNRA, trading at $170.09, is still within 5% of a $164.10 buy point after breaking out of a 1st stage cup with handle base.

/as usual, your mileage may vary, always do your own homework

Weekly Watch List

ALXN (7/24/11, +87.30%)
AAPL (4/29/12, +14.64%)
ALGN (9/16/12, +0.00%)
TDG (9/9/12, +1.45%)
FLT (9/2/12, +3.36%)
TJX (3/25/12, +20.27%)
CF (9/9/12, +4.06%)
VAL (7/01/12, +9.58%)
ROST (9/9/12, -0.13%)
JAH (9/9/12, +6.44%)
EBAY (9/16/12, +0.00%)

Additions:
ALGN (9/16/12, +0.00%)
EBAY (9/16/12, +0.00%)

Subtractions:
None

Last week, all the major U.S. indexes continued to log gains. The NYSE composite jumped 2.7%, the Dow vaulted 2.2%, the S&P 500 surged 1.9%, and the NASDAQ climbed 1.5%. The IBD outlook remains at “confirmed uptrend”. After last week’s Bernanke induced synthetic money sugar high, it wouldn’t be surprising to see a bit of consolidation this week. That said, this rally is the perfect example of why you need to ignore all the noise and focus on what the market is actually doing. If you’d have listened to the negativity of the pundits and impending doom of conventional wisdom for the last month or so, you’d still be sitting on the sidelines. Continue to ride the uptrend until the market tells you it’s over.

This week three of the watch list stocks are at or near proper buy points. ALXN, trading at $110.47, is just past a $110.06 buy point, off of a 4th stage flat base, but good volume is still lacking. TJX, trading at $46.46, has formed a five weeks tight pattern with a potential buy point of $46.77. CF, trading at $223.69, found good volume support at its ten week line and is still in buy range up to $229.16.

/as usual, your mileage may vary, always do your own homework

Weekly Watch List

ALXN (7/24/11, +87.54%)
AAPL (4/29/12, +12.84%)
TDG (9/9/12, +0.00%)
FLT (9/2/12, +2.18%)
ROST (9/9/12, +0.00%)
TJX (3/25/12, +18.69%)
CF (9/9/12, +0.00%)
VAL (7/01/12, +5.26%)
JAH (9/9/12, +0.00%)

Additions:
CF (9/9/12, +0.00%)
JAH (9/9/12, +0.00%)
ROST (9/9/12, +0.00%)
TDG (9/9/12, +0.00%)

Subtractions:
GNC (9/2/12, +3.89%)
TFM (6/17/12, +10.06%)
ULTA (8/19/12, +10.55%)

Last week, the major U.S. indexes all pushed higher. The NYSE composite popped 2.7%, the NASDAQ climbed 2.3%, the S&P 500 rose 2.2%, and the Dow added 1.6%. The IBD outlook remains at “confirmed uptrend”. The main events this week will be the FOMC meeting as well as an expected ruling on Wednesday by a German court as to whether or not Germany can participate in the European bailout fund.

This week three of the watch list stocks are at or near proper buy points. ALXN, trading at $110.61, broke out of a 4th stage flat base on disappointing volume and sits just above a $110.06 buy point. TJX, trading at $45.85, has formed a four weeks tight pattern with a potential buy point of $46.77. VAL, trading at $55.25, is still within 5% of a $53.85 buy point after breaking out of a 2nd stage base on base cup with handle pattern on light volume.

/as usual, your mileage may vary, always do your own homework

Weekly Watch List

AAPL (4/29/12, +10.32%)
ALXN (7/24/11, +81.77%)
FLT (9/2/12, +0.00%)
TJX (3/25/12, +18.53%)
ULTA (8/19/12, +2.34%)
GNC (9/2/12, +0.00%)
VAL (7/01/12, +1.62%)
TFM (6/17/12, +11.49%)

Additions:
FLT (9/2/12, +0.00%)
GNC (9/2/12, +0.00%)

Subtractions:
DG (4/8/12, +8.15%)
EBAY (8/26/12, +0.79%)
JAH (8/5/12, +1.64%)
ROST (7/22/12, +3.05%)

Last week, the major U.S. indexes moved lower again. The NASDAQ gave up 0.1%, the S&P 500 faded 0.3%, the NYSE composite dipped 0.4%, and the Dow lost 0.5%. The IBD outlook remains at “confirmed uptrend”. With summer vacations over, market volume should start to pick up ahead of Friday’s release of August employment situation data.

This week five of the watch list stocks are at or near proper buy points. ALXN, trading at $107.21, has formed a 4th stage square box flat base with a potential buy point of $110.06. FLT, trading at $43.18, is still within 5% of a $41,40 buy point after breaking out of a 1st stage cup base. TJX, trading at $45.79, has formed a three weeks tight pattern with a potential buy point of $46.77. ULTA, trading at $94.00, has formed a late, 6th stage cup base with a potential buy point of $98.52. VAL, trading at $53.34, has formed a 2nd stage base on base cup with handle pattern with a potential buy point of $53.85.

/as usual, your mileage may vary, always do your own homework